Krilogy Financial’s Kite Pharma, Inc. KITE Stock Holding History

Krilogy Financial’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-150	Closed	-$16K	–	876
2017 Q2	$16K	Hold	150	–	–	﹤0.01%	475
2017 Q1	$7K	Hold	150	–	–	﹤0.01%	558
2016 Q4	$7K	Hold	150	–	–	﹤0.01%	558
2016 Q3	$8K	Buy	150 +50	+50%	+$2.79K	﹤0.01%	556
2016 Q2	$5K	Hold	100	–	–	﹤0.01%	615
2016 Q1	$5K	Hold	100	–	–	﹤0.01%	545
2015 Q4	$6K	Hold	100	–	–	0.01%	307
2015 Q3	$6K	Buy	+100	New	+$6.29K	﹤0.01%	455

Other funds holding KITE

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCSAM

Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Krilogy Financial's KITE Position: Q3 2017 in Review

Krilogy Financial sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 150 shares — an estimated $16K sold.

Krilogy Financial first reported a position in KITE in Q3 2015 and held it in 8 quarters. The position peaked at $16K in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Krilogy Financial reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Krilogy Financial sold 150 Kite Pharma, Inc. shares in Q3 2017, an estimated $16K.
Krilogy Financial first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 8 quarters.
Krilogy Financial's Kite Pharma, Inc. position peaked at $16K in Q2 2017.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Krilogy Financial's 13F filing for Q3 2017, filed 15 Nov 2017.